1. [Home](https://www.g2.com/)
2. ...
3. [Machine Learning Software](https://www.g2.com/categories/machine-learning)
4. [MedAware Discussions](https://www.g2.com/products/medaware/discuss)

[
 ![MedAware](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_f9c00a9b5a54c1d1828b36d9cd515ff1/medaware.jpg "MedAware")
](/products/medaware/reviews)

# MedAware Discussions

MedAware is an AI-driven medication safety monitoring platform designed to identify and prevent medication-related risks throughout the entire patient journey. By integrating seamlessly within existing health data systems and connected devices, MedAware provides a continuous safety layer that enhances patient care and safeguards healthcare providers. Key Features and Functionality: - AI-Powered Risk Identification: Utilizes advanced machine learning algorithms and outlier detection mechanisms to detect prescribing anomalies and potential adverse drug events. - Continuous Monitoring: Operates 24/7 to provide real-time clinical insights at all stages of medication access and delivery, ensuring patient safety even when they are not actively seeking care. - Seamless Integration: Designed to integrate within existing Electronic Health Records (EHRs) and health data systems, facilitating easy adoption without disrupting current workflows. - High Clinical Relevance: Delivers accurate and timely alerts with a low alert burden, leading to significant improvements in provider behavior and patient outcomes. Primary Value and Problem Solved: MedAware addresses the critical issue of medication errors, which harm an estimated 1.2 million Americans annually. Traditional Clinical Decision Support (CDS) systems often fail to catch a significant portion of these errors. By providing a personalized and continuous monitoring system, MedAware enhances patient safety, reduces the risk of adverse drug events, and supports healthcare providers in delivering optimal care.

## Be the first to start the conversation

Get answers from real professionals in the G2 community.